EU-TTG IGA AND EU-TTG IGG— 510(k) K102964

Substantially Equivalent

Grifols USA, Inc.

FDA 510(k) clearance K102964 for EU-TTG IGA AND EU-TTG IGG, Substantially Equivalent on 2011-03-07. Applicant: Grifols USA, Inc..

Clearance details

Applicant
Grifols USA, Inc.
Product code
Code MVM
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Los Angeles, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.